{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:59:45Z","timestamp":1778126385365,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10792-018-0844-z","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T02:00:06Z","timestamp":1517882406000},"page":"687-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-0725","authenticated-orcid":false,"given":"Hande","family":"Celiker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Toker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isik","family":"Kaygusuz Atagunduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"844_CR1","doi-asserted-by":"publisher","first-page":"895105","DOI":"10.1155\/2015\/895105","volume":"2015","author":"O Annibali","year":"2015","unstructured":"Annibali O, Chiodi F, Sarlo C et al (2015) Rituximab as single agent in primary MALT lymphoma of the ocular adnexa. Biomed Res Int 2015:895105. \n                    https:\/\/doi.org\/10.1155\/2015\/895105","journal-title":"Biomed Res Int"},{"key":"844_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/path.1711740106","volume":"174","author":"AC Wotherspoon","year":"1994","unstructured":"Wotherspoon AC, Hardman-Lea S, Isaacson PG (1994) Mucosa-associated lymphoid tissue (MALT) in the human conjunctiva. J Pathol 174:33\u201337. \n                    https:\/\/doi.org\/10.1002\/path.1711740106","journal-title":"J Pathol"},{"issue":"8","key":"844_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1634\/theoncologist.2015-0109","volume":"20","author":"B Kiesewetter","year":"2015","unstructured":"Kiesewetter B, Ferreri AJ, Raderer M (2015) Chemoimmunotherapy for mucosa-associated lymphoid tissue-type lymphoma: a review of the literature. Oncologist 20(8):915\u2013925. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0109","journal-title":"Oncologist"},{"key":"844_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","volume":"31","author":"E Kimby","year":"2005","unstructured":"Kimby E (2005) Tolerability and safety of rituximab (MabThera). Cancer Treat Rev 31:456\u2013473. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2005.05.007","journal-title":"Cancer Treat Rev"},{"key":"844_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","volume":"29","author":"C Freeman","year":"1972","unstructured":"Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252\u2013260","journal-title":"Cancer"},{"key":"844_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","volume":"10","author":"PJ Fitzpatrick","year":"1984","unstructured":"Fitzpatrick PJ, Macko S (1984) Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys 10:333\u2013340","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"844_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/028418601750288217","volume":"40","author":"K Sasai","year":"2001","unstructured":"Sasai K, Yamabe H, Dodo Y (2001) Non-Hodgkin\u2019s lymphoma of the ocular adnexa. Acta Oncol 40:485\u2013490","journal-title":"Acta Oncol"},{"key":"844_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/107327481602300208","volume":"23","author":"J Guffey Johnson","year":"2016","unstructured":"Guffey Johnson J, Terpak LA, Margo CE, Setoodeh R (2016) Extranodal marginal zone B-cell lymphoma of the ocular adnexa. Cancer Control 23:140\u2013149","journal-title":"Cancer Control"},{"key":"844_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","volume":"88","author":"K Harada","year":"2014","unstructured":"Harada K, Murakami N, Kitaguchi M et al (2014) Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 88:650\u2013654. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.235","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"844_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","volume":"108","author":"D Decaudin","year":"2006","unstructured":"Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451\u20131460. \n                    https:\/\/doi.org\/10.1182\/blood-2006-02-005017","journal-title":"Blood"},{"key":"844_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/sonc.2003.50025","volume":"30","author":"P Johnson","year":"2003","unstructured":"Johnson P, Glennie M (2003) The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 30:3\u20138. \n                    https:\/\/doi.org\/10.1053\/sonc.2003.50025","journal-title":"Semin Oncol"},{"key":"844_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","volume":"73","author":"H N\u00fcckel","year":"2004","unstructured":"N\u00fcckel H, Meller D, Steuhl KP, D\u00fchrsen U (2004) Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 73:258\u2013262. \n                    https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00299.x","journal-title":"Eur J Haematol"},{"key":"844_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3109\/02713683.2014.959605","volume":"40","author":"S Tuncer","year":"2015","unstructured":"Tuncer S, Tany\u0131ld\u0131z B, Basaran M, Buyukbabani N, Dogan O (2015) Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma: single institution experience. Curr Eye Res 40:780\u2013785. \n                    https:\/\/doi.org\/10.3109\/02713683.2014.959605","journal-title":"Curr Eye Res"},{"key":"844_CR14","first-page":"1578","volume":"90","author":"AJ Ferreri","year":"2005","unstructured":"Ferreri AJ, Ponzoni M, Martinelli G et al (2005) Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 90:1578\u20131579","journal-title":"Haematologica"},{"key":"844_CR15","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.leukres.2008.05.018","volume":"33","author":"T Salepci","year":"2009","unstructured":"Salepci T, Seker M, Kurnaz E et al (2009) Conjunctival malt lymphoma successfully treated with single agent rituximab therapy. Leuk Res 33:e10\u2013e13. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2008.05.018","journal-title":"Leuk Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0844-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:58:23Z","timestamp":1567234703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0844-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0844-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}